Global pharmaceutical company Cencora, Inc. recently announced the appointment of Pawan Verma as Executive Vice President and ...

The pharmaceutical value chain model depicted in Figure 1 covers a full range of activities that are required to bring a product from conception to final consumer. The key players in the chain are ...

the FDA Orange Book, and SEC filings to predict the revenues of the 14 large-cap pharmaceutical companies from 2009E–2015E (see Supplementary information S1 (box) for details of the analysis).

ANIP may be acquired soon with a potential offer exceeding $8 billion and contingent on FDA approval of a new drug filed in ...

There are certain phrases that Wachuka Gichohi finds difficult to hear after enduring four years of living with long COVID, marked by debilitating fatigue, pain, panic attacks and other symptoms ...

On Wednesday, Zentalis Pharmaceuticals Inc (ZNTL) stock saw a modest uptick, ending the day at $3.92 which represents a slight increase of $0.21 or 5.66% from the prior close of $3.71. The stock ...

Takeda, a Japanese pharmaceutical company with US headquarters in Cambridge, has announced the latest of several rounds of layoffs it’s been conducting this year, bringing the total to nearly ...

On Friday, Recursion Pharmaceuticals Inc (RXRX) stock saw a modest uptick, ending the day at $7.1 which represents a slight increase of $0.17 or 2.45% from the prior close of $6.93. The stock opened ...

State and federal regulatory scrutiny has deterred private equity investment in healthcare providers, PitchBook analysts said.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

With a Price to Book ratio of 60.89 ... and PS ratios are all high compared to its peers in the Pharmaceuticals industry, indicating potentially overvalued stock. On the other hand, Eli Lilly's ...

Teva Pharmaceutical Industries (TEVA ... Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities.